IRLA

39.7050.59%
MB

Mark Brody

Member of Clinical Advisory Board

Mark Brody M.D serves as Member of Clinical Advisory Board at IRulya Therapeutics Inc. (formerly known as Quince Therapeutics, Inc.) (formerly known as Cortexyme, Inc.).

Positions